Oxera study

Oxera study concludes UK generic medicines market functioning well.

Read more


C+D Awards Evening 2019 - Highlights Video

Accord UK sponsored the ‘Above and Beyond’ category at the C+D awards last week. Well done to pharmacist, Hassan Riaz, who won the above and beyond category.

Read more


Accord UK attends Clinical Pharmacy Congress 2019

Accord-UK were pleased to exhibit at the Clinical Pharmacy Congress 2019 last week

Read more


Accord UK sponsoring C+D’s ‘Above and Beyond’ Award tomorrow!

Accord UK will be attending the C+D Awards evening tomorrow night. These awards recognise best practice and reward excellence in community pharmacy.

Read more


Accord-UK exhibit at the British Society for Rheumatology Conference 2019

Accord-UK were pleased to exhibit at the British Society for Rheumatology Conference this week.

Read more


Celebrating ‘National Apprenticeship Week 2019’

Read more


International suppliers meet at Accord Fawdon to celebrate growing together in partnership

Accord Fawdon recently hosted a special event to celebrate its supplier partnerships. 

Read more


Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare

Taipei, Taiwan and Harrow, England, February 11, 2019 – An exclusive license agreement for the commercialisation of Foresee Pharmaceutical’s (6576.TWO) novel FP-001 program (leuprorelin depot...

Read more


The Falsified Medicines Directive – Sandra Lee’s interview published in Pharmacy Business – February 2019 edition

Sandra Lee, Managing Director of Operations, explains why FMD is important and how the industry is preparing.

Read more